How Regulatory Science Benefits Patients

What is Regulatory Science? (video-full version)

FDA Expert Panel on Food Allergies

Opportunities to Engage With the FDA About Qualification During Biomarker Development

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA Direct: Combating Rare Diseases at the FDA

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces

FDA’s Rare Disease Day 2026 – An Event for Patients

SmartTots to Help Make Anesthetics and Sedatives Safer for Children

Don’t be Influenced (PSA, 30 seconds)

FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA-USP-AAM | D1S4 – Q&A Discussion Panel